Outset Medical reported a net loss of $19.5 million on revenue of $28.9 million for the fourth quarter of 2025. While revenue decreased by 2% year-over-year, gross profit increased by 14% and gross margin expanded significantly to 42.4%. The company also reduced operating expenses by 8% and improved its cash position, ending the year with $173 million in total cash.
Net revenue for Q4 2025 was $28.9 million, a 2% decrease compared to Q4 2024.
Gross profit increased by 14% to $12.2 million in Q4 2025, with gross margin expanding to 42.4% (42.9% non-GAAP).
Operating expenses declined by 8% to $29.9 million in Q4 2025, reflecting efforts to streamline operations.
Net loss improved to $19.5 million in Q4 2025, compared to a net loss of $25.6 million in Q4 2024.
Outset Medical provided revenue guidance for 2026 between $125 million and $130 million, representing a 5% to 9% increase over 2025. The company also expects non-GAAP gross margin to be in the low to mid-40% range for the year.
Visualization of income flow from segment revenue to net income
Analyze how earnings announcements historically affect stock price performance